The new report from business intelligence provider Visiongain offers an updated outlook for the global market for cardiovascular ultrasound. Visiongain assesses that the cardiovascular ultrasound market will generate revenues of $xyz million by 2030 and there will be around 177 thousand units in the world. Ultrasound is defined as a sound wave with 20,000 Hertz (Hz) and higher frequencies. Three broad applications can be divided into the clinical utility of an ultrasound instrument: surgical, treatment and diagnostic. Today, more and more surgeons use ultrasound to aid in the imaging of less invasive surgery. Minimally invasive image-guided ultrasound procedures allow for rapid patient recovery and a short stay in the hospital. In conjunction with other real-time imaging procedures such as MRI, ultrasonic, image-guided interventions provide surgeons with more meaningful clinical information while performing an operation.
Ultrasounds as an imaging surgical tool are becoming ever more important globally. Ultrasound technology is developing quickly and several companies are developing contactless, user-friendly devices for an enhanced user experience. The use of very concentrated ultrasound has increased during neurosurgery. The current period of fast growth of medical ultrasound is, as it has a major clinical impact. The quality of the images produced by ultrasound instruments has enormously increased and the time taken for pictures/turnaround has decreased significantly.
Global cardiovascular ultrasound market was valued at $xyz million, in 2019 and is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at market value of $xyz million, by 2030. The market is anticipated to grow at a CAGR of xyz% in the first half of the forecast period while the second half of the forecast period is anticipated to grow at CAGR of xyz%. This is an example of the business critical headline that you need to know about – and more importantly, you need to read Visiongain’s objective analysis of how this will impact your company and the industry more broadly. How are you and your company reacting to this news? Are you sufficiently informed?
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Rising Incidence of Cardiovascular Disorders and Other Lifestyle Related Disorders
In 2018, approximately 17.9 million deaths from CVDs accounted for 31% of the world’s deaths. An estimated 7.4 millions of these deaths were due to cardiac coronary heart disease. The overall prevalence of cardiovascular disease in 2019 was estimated at 522,7 million but the prevalence was significantly varied by country. Death rates were highest in Central Asia and Eastern Europe, but also in Iraq, Afghanistan, and many countries of the South Pacific island.
Increasing Demand for Minimally Invasive Surgeries
The worldwide focus is on minimally invasive surgeries (MIS). MIS is a successful practice and an alternative to conventional surgery and robotic operation. The minimum invasive procedure for cardiac procedures includes the repair and replacement mitral valve, repair of aortic valves, remediation of auricular septal defects, coronary artery bypassing, removal of cardiac tumors and removal of atrial fibrillation. Combined with medical progress, open surgery in general will soon be outdated and the most accepted method of treatment will be minimally invasive. This success increases cardiovascular ultrasound market growth further. The success of these procedures
Increasing Adoption of Telemedicine, Remote Patient Monitoring and Home Healthcare
Remote interpretation of cardiology investigations and patient data is a fast-emerging telecardiology industry. The aim of telecardiology is to provide cardiologist and other caregivers as soon as possible with the necessary and reliable information, preventing the patient’s condition from deteriorating, without having to travel either for patients or for cardiologists. Recent studies have recognized home-based telemedicine management programmes. Cryptogenic heart failure and hypertension monitoring and management programs, acute ST elévation IM diagnostics and treatment, and the monitoring of patients with electronic implantable devices, amongst other activities, are the most important programs for disease management. Overall, the increased adoption of telemedicine, remote monitoring and home health care drives the cardiovascular devices market as numerous benchmarks are launched and attractive.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in the medical imaging sector. Visiongain’s new study tells you and tells you NOW.
In this brand-new report, you will receive 214 in-depth tables, charts and graphs– all unavailable elsewhere.
The 386-page report provides clear detailed insight into the global market for cardiovascular ultrasound. It reveals the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you will be better informed and ready to act.
Report Scope
• Global cardiovascular ultrasound market forecasts from 2020-2030
Market by Test Type
• Transthoracic Echocardiography
• Transoesophageal Echocardiography
• Stress Echocardiography
• Other Test Types
Market by Technology
• 2D Technology
• 3D & 4D Technology
• Doppler Imaging
• Other Technology
Market by Display Type
• Colour Display
• Black&White Display
• Other Display Type
Market by Portability
• Fixed Devices
• Portable Devices
• Hand-Held Devices
• Other Portability
Market by End-user
• Hospitals
• Ambulatory Centers
• Diagnostic Centers
• Regional cardiovascular ultrasound market forecasts from 2020-2030 covering
• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa
• Country level cardiovascular ultrasound forecasts from 2020-2030 covering
• US
• Canada
• Mexico
• UK
• Germany
• Spain
• China
• Japan
• Brazil
• UAE
• India
• Australia
• South Korea
• RoW
• Analysis of the key factors driving growth in the global, regional and country level cardiovascular ultrasound markets from 2020-2030
Global cardiovascular ultrasound market by end-user was valued at US$xyz million, in 2019 and is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at market value of US$xyz million, by 2030. Hospitals is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at a market value of US$xyz million, by 2030. Diagnostic Centers is expected to grow at a CAGR of xyz% from 2020-2030 to reach at a market value of US$xyz million, by 2030.
To access the data contained in this document please email contactus@visiongain.com
Profiles and competitive positioning map of the leading 20 cardiovascular ultrasound companies:
• Canon Medical Systems Corporation
• Koninklijke Philips N.V.
• Hitachi, Ltd.
• Fujifilm Medical Systems
• GE Healthcare
• Siemens Healthiness AG
• Toshiba Medical System Corporation
• Samsung Medison
• Mindray Medical International Limited
• Hutchison China Meditech
• Cardinal Health, Inc.
• Intelligent Ultrasound Group PLC
• Elbit Medical Technologies Ltd
• SuperSonic Imagine SA
• Abbott Laboratories
• Boston Scientific Corporation
• Stryker Corporation
• Esaote SpA
• KPI Healthcare
• BK Ultrasound
How will you benefit from this report?
• This report will keep your cardiovascular ultrasound knowledge base up to speed. Don’t get left behind
• This report will reinforce strategic decision decision-making based upon definitive and reliable market data
• You will learn how to exploit new cardiovascular ultrasound technological trends
• You will be able to realise your company’s full potential within the market
• You will better understand the competitive landscape and identify potential new business opportunities & partnerships
Who should read this report?
• Anyone within the medical imaging industry & value chain
• Medical Imaging Associations
• Ultrasound suppliers
• Manufacturers of Ultrasound Systems
• Manufacturers of Ultrasound Equipment
• Manufacturers of Ultrasound Product Components
• Ultrasound marketing and business analysis departments
• Investment analysts
• Investment consultancies
• Medical Device industry investors
• Medical Imaging market consultancy
• Governmental departments & agencies
• New product development (NPD) managers & Specialists
• Ultrasound buyers
• Ultrasound Service Providers
• CEO’s
• COO’s
• CIO’s
• Business development managers
• Marketing managers
• Medical associations
Visiongain’s study is intended for anyone requiring commercial analyses for the cardiovascular ultrasound market and leading companies. You will find data, trends and predictions.
Buy our report today Global Cardiovascular Ultrasound Market Report 2020-2030: Forecasts by Test Type (Transthoracic Echocardiography, Transoesophageal Echocardiography, Stress Echocardiography), Display Type (Colour Display, Black & White Display), by Technology (2D, 3D, 4D), by End-User (Hospitals, Ambulatory Centers, Diagnostic Centers), by Portability (Fixed Devices, Portable Devices, Hand-Held Devices) PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Ultrasound Overview
1.2 Global Cardiovascular Ultrasound Market Segmentation
1.3 Market Definition
1.3.1 Ultrasound Imaging Technology
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Why You Should Read This Report?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
2. Overview of Cardiovascular Disease Area
2.1 Arrhythmia
2.1.1 Atrial fibrillation (AF)
2.1.2 Bradycardia
2.1.3 Tachycardia (Atrial and Ventricular)
2.1.4 Ventricular Fibrillation
2.1.5 Premature Contraction
2.1.6 Disease Detection
2.1.7 Treatment Options
2.2 Cardiomyopathy
2.2.1 Dilated Cardiomyopathy (DCM)
2.2.2 Hypertrophic Cardiomyopathy (HCM)
2.2.3 Restrictive Cardiomyopathy
2.2.4 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
2.2.5 Disease Detection
2.2.6 Treatment Options
2.3 Coronary Heart Disease
2.3.1 Obstructive Coronary Artery Disease
2.3.2 Non-obstructive Coronary Artery Disease
2.3.3 Spontaneous Coronary Artery Dissection (SCAD)
2.3.4 Disease Detection
2.3.5 Fractional flow reserve (FFR)
2.3.6 Treatment Options
2.4 Myocardial Infarction
2.4.1 Disease Detection
2.4.2 Treatment Options
2.5 Congestion Heart Failure
2.5.1 Disease Detection
2.5.2 Treatment Options
2.6 Congenital Heart Disease (CHD)
2.6.1 Disease Detection
2.6.2 Treatment Options
2.7 Heart Infections
2.7.1 Disease Detection
2.7.2 Treatment Options
2.8 Valvular Heart Disease
2.8.1 Disease Detection
2.8.2 Treatment Options
2.9 Procedures
2.9.1 Cardiac Resynchronization Therapy (CRT)
2.9.2 Heart Transplantation
2.9.3 Coronary Artery Bypass Surgery
2.9.4 Valve Replacement
2.9.5 Beating Heart Surgery
2.9.6 Transmyocardial Revascularization Surgery
2.9.7 Balloon Valvuloplasty
2.9.8 Renal Denervation Surgery
3. Introduction Medical Ultrasound Technology
3.1 Technology Background
3.2 Application of Medical Ultrasound Devices
3.2.1 Diagnostic Applications
3.3 Therapeutic Applications
3.3.1 Thermal Medical Applications of Ultrasound
3.3.2 Non-thermal Medical Applications of Ultrasound
3.4 Different Modalities of Ultrasound Devices
3.4.1 Different modes are utilized to examine various tissues:
3.5 Ultrasound Device Types
3.5.1 Emerging Ultrasound Technology Trends
3.5.2 Ultrasound Elastography (UE)
3.5.3 Strain Elastography (SE)
3.5.4 Shear Wave Elastography (SWE)
3.5.5 Transient Elastography (TE)
3.5.6 Acoustic Radiation Force Impulse (ARFI) Imaging
3.5.7 Contrast Enhanced Ultrasound (CEUS)
3.5.8 Point-of-care Ultrasound Systems
3.5.9 Fusion Imaging or Hybrid Imaging Technology
3.6 Echocardiography (Echo)
3.6.1 Transthoracic Echocardiogram
3.6.2 Transesophageal Echocardiogram (TOE) Test
3.6.3 Stress Echocardiogram
3.6.4 Dobutamine Stress Echocardiogram Test
3.6.5 Intravascular Ultrasound
3.6.6 Three-Dimensional Echocardiogram
3.6.7 Fetal Echocardiography
3.6.8 Advancements
3.6.9 Other Advancements
4. Global Cardiovascular Ultrasound Market Analysis
4.1 Global Cardiovascular Ultrasound Market by Value
4.2 Global Cardiovascular Ultrasound Market by Volume
4.3 Regional Cardiovascular Ultrasound Market by Value
4.4 Regional Cardiovascular Ultrasound Market by Volume
4.5 Global Cardiovascular Ultrasound Market by Test Type
4.6 Global Cardiovascular Ultrasound Market by Technology
4.7 Global Cardiovascular Ultrasound Market by Display Type
4.8 Global Cardiovascular Ultrasound Market by Portability
4.9 Global Cardiovascular Ultrasound Market by End-User
5. Global Market Dynamics
5.1 Drivers: Global Impact Analysis
5.1.1 Rising Incidence of Cardiovascular Disorders and Other Lifestyle Related Disorders
5.1.2 Growing Geriatric Population
5.1.3 Technological Advancements
5.1.4 Increasing Demand for Minimally Invasive Surgeries
5.1.5 Increasing Adoption of Telemedicine, Remote Patient Monitoring and Home Healthcare
5.1.6 Integration of IT to Increase Market Growth
5.1.7 Cardiovascular Information System
5.2 Restraints: Global Impact Analysis
5.2.1 Regulatory Constraints
5.2.2 Reimbursement Issues
5.2.3 Inflated Cost of Devices
5.2.4 Slow Adoption of Technologies
5.2.5 Intense Competition
5.2.6 Unfavourable Impact of Foreign Currency Exchange
6. Global Cardiovascular Ultrasound Market Analysis by Test Type
6.1 Transthoracic Echocardiography Cardiovascular Ultrasound Market by Region
6.2 Transoesophageal Echocardiography Cardiovascular Ultrasound Market by Region
6.3 Stress Echocardiography Cardiovascular Ultrasound Market by Region
6.4 Other Test Types Cardiovascular Ultrasound Market by Region
7. Global Cardiovascular Ultrasound Market Analysis by Technology
7.1 2D Technology Cardiovascular Ultrasound Market by Region
7.2 3D & 4D Technology Cardiovascular Ultrasound Market by Region
7.3 Doppler Imaging Cardiovascular Ultrasound Market by Region
7.3.1 "Bedside" or Continuous Wave Doppler
7.3.2 Duplex Doppler
7.3.3 Colour Doppler
7.3.4 Medical Uses
7.4 Other Technology Cardiovascular Ultrasound Market by Region
8. Global Cardiovascular Ultrasound Market Analysis by Display Type
8.1 Colour Display Cardiovascular Ultrasound Market by Region
8.2 Black&White Display Cardiovascular Ultrasound Market by Region
8.3 Other Display Type Cardiovascular Ultrasound Market by Region
9. Global Cardiovascular Ultrasound Market Analysis by Portability
9.1 Fixed Devices Cardiovascular Ultrasound Market by Region
9.2 Portable Devices Cardiovascular Ultrasound Market by Region
9.3 Hand-Held Devices Cardiovascular Ultrasound Market by Region
9.4 Other Portability Cardiovascular Ultrasound Market by Region
10. Global Cardiovascular Ultrasound Market Analysis by End-User
10.1 Hospitals Cardiovascular Ultrasound Market by Region
10.2 Ambulatory Centres Cardiovascular Ultrasound Market by Region
10.3 Diagnostic Centres Cardiovascular Ultrasound Market by Region
10.3.1 Diagnostic Laboratories
10.3.2 Research Laboratories
11. North America Cardiovascular Ultrasound Market Analysis
11.1 Increasing Aging Population in North America
11.2 Increasing Prevalence of Cardiovascular Diseases
11.3 Increased Adoption of Advanced Ultrasound Modalities
11.4 Growing Market Demand for Minimally Invasive Treatments Using Ultrasound
11.5 North America Ultrasound Market Driven by Growing Point-of-Care (POC) Segment
11.6 Rising Incidence of Chronic and Lifestyle-related Diseases in North America
11.7 Cost Containment and Healthcare Reforms
11.8 Impact of the Patient Protection and the Affordable Care Act of 2010 on the U.S. Ultrasound Market
11.9 Lack of Skilled Diagnostic Medical Sonographers Professionals in the United States
11.10 Increased Cost Sharing or Co-pay
11.11 Medicare Competitive Bidding Limiting Market Penetration
11.12 North America Cardiovascular Ultrasound Market by Value
11.13 North America Cardiovascular Ultrasound Market by Volume
11.14 North America Cardiovascular Ultrasound Market by Test Type
11.15 North America Cardiovascular Ultrasound Market by Technology
11.16 North America Cardiovascular Ultrasound Market by Display Type
11.17 North America Cardiovascular Ultrasound Market by Portability
11.18 North America Cardiovascular Ultrasound Market by End-User
11.19 North America Cardiovascular Ultrasound Market by Country
11.20 United States
11.20.1 United States Cardiovascular Diseases (CVD) Trends
11.20.2 United States heart disease projections to 2023
11.21 Canada
11.21.1 Cardiovascular Diseases Trend in Canada
12. Europe Cardiovascular Ultrasound Market Analysis
12.1 Growing Aging Population of Europe
12.2 Increase in Ultrasound Procedure Volumes in the United Kingdom and Germany
12.2.1 United Kingdom
12.2.2 Germany
12.3 Austerity Measures Introduced Throughout Europe
12.4 Lack of Adequately Trained Sonographers in Europe
12.5 Increased Competitive Product Pricing and Mandatory Tendering
12.6 Europe Cardiovascular Ultrasound Market by Value
12.7 Europe Cardiovascular Ultrasound Market by Volume
12.8 Europe Cardiovascular Ultrasound Market by Test Type
12.9 Europe Cardiovascular Ultrasound Market by Technology
12.10 Europe Cardiovascular Ultrasound Market by Display Type
12.11 Europe Cardiovascular Ultrasound Market by Portability
12.12 Europe Cardiovascular Ultrasound Market by End-User
12.13 Europe Cardiovascular Ultrasound Market by Country
12.13.1 Germany
12.13.2 United Kingdom
12.13.3 France
12.13.5 Rest of Europe
13. Asia-Pacific Cardiovascular Ultrasound Market Analysis
13.1 Aging Population
13.2 Lifestyle Vicissitudes Increasing Cardiovascular Diseases in Asia-Pacific Region
13.3 Favourable Macro-Economic Profile of India
13.3.1 Restructuring Indian Health Policies
13.3.2 Medical Tourism
13.3.3 Resilience to the Recession
13.3.4 Impact of the Chinese Government’s 2012 Healthcare Reform on Medical Ultrasound Device Market
13.4 Local Ultrasound Device Manufacturers in China
13.5 Challenging Distribution Network in China
13.6 Strengthening Ultrasound Regulations in India
13.7 Lack of Access to Healthcare Services in India
13.8 Market Penetration Difficulties in Japan
13.9 Asia-Pacific Cardiovascular Ultrasound Market by Value
13.10 Asia-Pacific Cardiovascular Ultrasound Market by Volume
13.11 Asia-Pacific Cardiovascular Ultrasound Market by Test Type
13.12 Asia-Pacific Cardiovascular Ultrasound Market by Technology
13.13 Asia-Pacific Cardiovascular Ultrasound Market by Display Type
13.14 Asia-Pacific Cardiovascular Ultrasound Market by Portability
13.15 Asia-Pacific Cardiovascular Ultrasound Market by End-User
13.16 Asia-Pacific Cardiovascular Ultrasound Market by Country
13.16.1 China
13.16.2 Japan
13.16.3 India
13.16.4 South Korea
14. Middle East & Africa Cardiovascular Ultrasound Market Analysis
14.1 Increasing Per Capita Expenditure and Favourable Government Regulations for Imported Devices in Africa
14.2 Significant Government Support for Improvement of Health Indicators in Saudi Arabia
14.3 Improving Economy and Expanding NHI Services in South Africa
14.4 Shortfall of Medical Practitioners and Increasing Demand for Teleradiology in Community-based Settings
14.5 Increasing Demand for Radiological Services in Africa
14.6 Limited Healthcare Infrastructure and Health Insurance Coverage in Africa
14.7 Inherent Political/Economic Hurdles Limiting the Growth of Medical Devices Market
14.8 Poor Logistics and Distribution Network in Africa
14.9 Middle East & Africa Cardiovascular Ultrasound Market by Value
14.10 Middle East & Africa Cardiovascular Ultrasound Market by Volume
14.11 Middle East & Africa Cardiovascular Ultrasound Market by Test Type
14.12 Middle East & Africa Cardiovascular Ultrasound Market by Technology
14.13 Middle East & Africa Cardiovascular Ultrasound Market by Display Type
14.14 Middle East & Africa Cardiovascular Ultrasound Market by Portability
14.15 Middle East & Africa Cardiovascular Ultrasound Market by End-User
14.16 Middle East & Africa Cardiovascular Ultrasound Market by Country
15. Latin America Cardiovascular Ultrasound Market Analysis
15.1 Improving Healthcare Policies and Insurance Plans in Brazil
15.2 Expanding Healthcare Opportunities in Mexico
15.3 Diverse Regulatory Environment
15.4 Latin America Cardiovascular Ultrasound Market by Value
15.5 Latin America Cardiovascular Ultrasound Market by Volume
15.6 Latin America Cardiovascular Ultrasound Market by Test Type
15.7 Latin America Cardiovascular Ultrasound Market by Technology
15.8 Latin America Cardiovascular Ultrasound Market by Display Type
15.9 Latin America Cardiovascular Ultrasound Market by Portability
15.10 Latin America Cardiovascular Ultrasound Market by End-User
15.11 Latin America Cardiovascular Ultrasound Market by Country
15.12 Brazil
15.12.1 Cardiovascular Disease Trends
15.13 Argentina
15.13.1 Cardiovascular Diseases Trends in Argentina
15.14 Mexico
16. International Regulatory Landscape
16.1 United States
16.1.1 FDA Medical Devices Regulations
16.1.2 Regulatory Approval Process for Medical Ultrasound Devices
16.2 Canada
16.3 Europe Regulatory and Legislative Requirements
16.3.1 (General) Medical Device Directive, MDD (93/42/EEC)
16.3.2 Active Implantable Medical Device Directive, AIMDD (90/383/EEC)
16.3.3 In-Vitro Diagnostic Medical Device Directive, IVDMDD (98/79/EC)
16.3.4 Proposal for Changes to the Medical Device Directive, MDD (93/42/EEC)
16.4 Japan
16.4.1 Marketing Authorization System
16.5 China Food and Drug Administration (CFDA)
16.5.1 Regulations on Medical Devices
16.5.2 Labelling and packaging regulations are also being updated.
16.6. South Korea
16.6.1 Korea Good Manufacturing Practice (KGMP).
16.7 Brazil
16.8 Argentina
16.9 Mexico
16.10 South Africa
16.11 Saudi Arabia
17. COVID-19 Impact Analysis
17.1 Demand for Ultrasound will be Uneven
17.2 Supply Chains are Being Disrupted
17.3 Overall Revenues will Likely Decline During the Crisis
18. Company Profiles
18.1 Canon Medical Systems Corporation
18.1.1 Business Overview
18.1.2 Canon Medical Systems Corporation Company Financials
18.1.3 Canon Medical Systems Corporation Company Recent Developments
Investment Announcement
18.1.4 Canon Medical system strategy and Highlights
18.1.5 Canon Medical Systems Corporation Primary Market Competitors 2020
18.2 Koninklijke Philips N.V.
18.2.1 Business Overview
18.2.2 Koninklijke Philips N.V. Company Financials
18.2.3 Koninklijke Philips N.V. Company Recent Developments
18.2.4 Koninklijke Philips N.V. Strategy and Highlights
18.2.5 Koninklijke Philips N.V. Primary Market Competitors 2020
18.3 Hitachi
18.3.1 Business Overview
18.3.2 Hitachi Company Financials
18.3.3 Hitachi Company Recent Developments
18.3.4. Hitachi Strategy and Highlights
18.3.5 Hitachi Primary Market Competitors 2020
18.4.1 Business Overview
18.4.2 Fujifilm Medical Systems Company Financials
18.4.3 Fujifilm Medical Systems Company Recent Developments
18.4.4 Fujifilm Medical Systems Strategy and Highlights
18.4.5 Fujifilm Medical Systems Primary Market Competitors 2020
18.5 GE Healthcare
18.5.1 Business Overview
18.5.2 GE Healthcare Company Financials
18.5.3 GE Healthcare Company Recent Developments
18.5.4 GE Healthcare, Strategy and Highlights
18.5.5 GE Healthcare, Primary Market Competitors 2020
18.6 Siemens Healthcare
18.6.1 Business Overview
18.6.2 Siemens Healthcare Company Financials
18.6.3 Siemens Healthcare Company Recent Developments
18.6.5 Siemens Healthcare Primary Market Competitors 2020
18.7 Toshiba Medical System Corporation
18.7.1 Business Overview
18.7.2 Toshiba medical system corporation Company Financials
18.7.3 Toshiba medical system corporation Company Recent Developments
18.7.5 Toshiba medical system corporation Primary Market Competitors 2020
18.8 Samsung Medison
18.8.1 Business Overview
18.8.2 Samsung Medison Company Financials
18.8.3 Samsung medison Company Recent Developments
18.8.4 Samsung Medison Strategy and Highlights
18.8.5 Samsung Medison Primary Market Competitors 2020
18.9 Mindray Medical International Limited
18.9.1 Business Overview
18.9.2 Mindray Medical International Limited Company Financials
18.9.3 Mindray Medical International Limited Company Recent Developments
18.9.4 Mindray Medical International Limited Primary Market Competitors 2020
18.10 Hutchison China Meditech
18.10.1 Business Overview
18.10.2 Hutchison China Meditech Company Financials
18.10.3 Chison china Meditech Company Recent Developments
18.10.5 Hutchison China Meditech Primary Market Competitors 2020
18.11 Cardinal Health Inc.
18.11.1 Business Overview
18.11.2 Cardinal Health Inc. Company Financials
18.11.3 Cardinal Health Inc. Company Recent Developments
18.11.4 Cardinal Health Inc. Primary Market Competitors 2020
18.12 Intelligent Ultrasound Group
18.12.1 Business Overview
18.12.2 Intelligent Ultrasound Group Company Financials
18.12.3 Intelligent Ultrasound Group, Company Recent Developments
18.12.4 Intelligent Ultrasound Group Primary Market Competitors 2020
18.13 Elbit Medical Technologies Ltd
18.13.1 Business Overview
18.13.2 Elbit Medical Technologies Ltd Company Financials
18.13.3 Elbit Medical Technologies Ltd Company Recent Developments
18.13.5 Elbit Medical Technologies Ltd Primary Market Competitors 2020
18.14 SuperSonic Imagine SA
18.14.1 Business Overview
18.14.2 SuperSonic Imagine SA Company Financials
18.14.3 SuperSonic Imagine SA Company Recent Developments
18.14.4 SuperSonic Imagine SA Primary Market Competitors 2020
18.15 Abbott Laboratories
18.15.1 Business Overview
18.15.2 Abbott Laboratories Company Financials
18.15.3 Abbott Laboratories Company Recent Developments
18.15.4 Abbott Laboratories Strategy and Highlights
18.15.5 Abbott Laboratories Primary Market Competitors 2020
18.16 Boston Scientific Corporation
18.16.1 Business Overview
18.16.2 Boston Scientific Corporation Company Financials
18.16.3 Boston Scientific Corporation Company Recent Developments
18.16.5 Boston Scientific Corporation Primary Market Competitors 2020
18.17 Strsyker Corporation
18.17.1 Business Overview
18.17.2 Stryker Corporation Company Financials
18.17.3 Stryker Corporation, Company Recent Development
18.17.4 Stryker Corporation Strategy and Highlights
18.17.5 Stryker Corporation Primary Market Competitors 2020
18.18 Esaote SpA
18.18.1 Business Overview
18.18.2 Esaote SpA,2020 Company Recent Developments
18.18.3 Esaote S.p.A. Primary Market Competitors 2020
18.19 KPI Healthcare
18.19.1 Business Overview
18.19.2 KPI Healthcare Company Key highlights
18.19.3 KPI Healthcare,2020 Primary Market Competitors 2020
18.20 BK Ultrasound
18.20.1 Business Overview
18.20.2 BK Medical Ultrasound Company Recent Developments
18.20.3 BK Ultrasound Primary Market Competitors 2020
19. Conclusion and Recommendations
19.1 Global Market
19.2 Technology Insight
19.3 Top End-User
19.4 Country Insights
19.5 Market Competition
19.6 Ultrasound Is Becoming Smaller and Smarter
19.7 Access is Important and Expanding
19.8 Technology Has Unlocked Handheld Capabilities
19.9 Startups Are Shaking Up the Market
19.10 The Latest in Cardiovascular Hand-Held Point-of-Care Ultrasound
20. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A About Visiongain
Appendix B Visiongain Report Evaluation Form
LIST OF TABLES
Table 1.1 Global Cardiovascular Ultrasound Market Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Summary Table 1.2: Global Market for Cardiovascular Devices, by Device Type, Through 2022($ Millions)
Table 2.1 Global Cardiovascular Surgical and Interventional Procedures in 2019
(Millions/%)
Table 2.2 CRT Treatment Cost in United States, 2019 ($)
Table 2.3 Number of Heart Transplants in USA, 2017-2019
Table 2.4 Average Heart Transplantation Therapy Cost in United States, 2019 ($)
Table 2.5 Cost of CABG Therapy, by Country, 2019 ($)
Table 2.6 Treatments and Cost Related to Valve Replacement in India, 2019 ($)
Table 3.1 Ultrasound Frequencies Used for Medical Examinations
Table 3.2 Medical Applications of Diagnostic Ultrasound
Table 4.1 Global Cardiovascular Ultrasound Market Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 4.2 Global Cardiovascular Ultrasound Market Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 4.3 Global Cardiovascular Ultrasound Market By Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 4.4 Global Cardiovascular Ultrasound Market By Region Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 4.5 Global Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 4.6 Global Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 4.7 Global Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 4.8 Global Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 4.9 Global Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 5.1 Average Estimated Percentage Prevalence of Lifestyle Diseases, 2019 (%)
Table 5.2 Advances in Cardiology
Table 5.3 Wearable Commercial Products for Monitoring Physiological Signs and Activities
Table 5.4 Recent FDA Recalls of Cardiovascular Devices
Table 6.1 Global Transthoracic Echocardiography Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 6.2 Global Transoesophageal Echocardiography Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 6.3 Global Stress Echocardiography Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 6.4 Global Other Test Type Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 7.1 Global 2D Technology Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 7.2 Global 3D & 4D Technology Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 7.3 Global Doppler Imaging Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 7.4 Global Other Technology Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 8.1 Global Colour Display Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 8.2 Global Black&White Display Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 8.3 Global Other Display Type Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 9.1 Global Fixed Devices Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 9.2 Global Portable Devices Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 9.3 Global Hand-Held Devices Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 9.4 Global Other Portability Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 10.1 Global Hospital Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 10.2 Global Ambulatory Centers Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 10.3 Global Diagnostic Centers Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.1 North America Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.2 North America Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 11.3 North America Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.4 North America Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.5 North America Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.6 North America Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.7 North America Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 11.8 North America Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.1 Europe Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.2 Europe Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 12.3 Europe Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.4 Europe Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.5 Europe Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.6 Europe Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.7 Europe Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 12.8 Europe Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.1 Asia-Pacific Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.2 Asia-Pacific Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 13.3 Asia-Pacific Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.4 Asia-Pacific Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.5 Asia-Pacific Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.6 Asia-Pacific Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.7 Asia-Pacific Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 13.8 Asia-Pacific Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.1 Middle East & Africa Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.2 Middle East & Africa Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 14.3 Middle East & Africa Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.4 Middle East & Africa Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.5 Middle East & Africa Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.6 Middle East & Africa Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.7 Middle East & Africa Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 14.8 Middle East & Africa Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.1 Latin America Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.2 Latin America Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Table 15.3 Latin America Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.4 Latin America Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.5 Latin America Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.6 Latin America Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.7 Latin America Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 15.8 Latin America Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Table 16.1 List of FDA Approved Ultrasound Devices
Table 16.2 Overview of Pharmaceutical Affairs Law (PAL) and Japanese Medical Devices Nomenclature (JMDN) Code and Related Codes According to the EU MDD
Table 18.1 Canon Medical Systems Corporation Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.2 Canon Medical Systems Corporation Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.3 Canon Medical Systems Corporation Total Operating Income 2015-2019 (US$m)
Table 18.4 Canon Medical Systems Corporation Total Net Income 2015-2019 (US$m, AGR%)
Table 18.5 Canon Medical Systems Corporation Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.6 Canon Medical Systems Corporation Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.7 Koninklijke Philips N.V. Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.8 Koninklijke Philips N.V. Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.9 Koninklijke Philips N.V. Total Operating Income 2015-2019 (US$m)
Table 18.10 Koninklijke Philips N.V. Total Net Income 2015-2019 (US$m, AGR%)
Table 18.11 Koninklijke Philips N.V. Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.12 Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.13 Hitachi Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.14 Hitachi Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.15 Hitachi Total Operating Income 2015-2019 (US$m)
Table 18.16 Hitachi Total Net Income 2015-2019 (US$m, AGR%)
Table 18.17 Hitachi Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.18 Hitachi Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.19 Fujifilm Medical Systems Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.20 Fujifilm Medical Systems Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.21 Fujifilm Medical Systems Total Operating Income 2015-2019 (US$m)
Table 18.22 Fujifilm Medical Systems Total Net Income 2015-2019 (US$m, AGR%)
Table 18.23 Fujifilm Medical Systems Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.24 Fujifilm Medical Systems Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.25 GE Healthcare Company Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.26 GE Healthcare Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.27 GE Healthcare Total Operating Income 2015-2019 (US$m)
Table 18.28 GE Healthcare Total Net Income 2015-2019 (US$m, AGR%)
Table 18.29 GE Healthcare Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.30 GE Healthcare Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.31 Siemens Healthcare Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.32 Siemens Healthcare Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.33 Siemens Healthcare Total Operating Income 2015-2019 (US$m)
Table 18.34 Siemens Healthcare Total Net Income 2015-2019 (US$m, AGR%)
Table 18.35 Siemens Healthcare Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.36 Siemens Healthcare Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.37 Toshiba medical system corporation Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.38 Toshiba medical system corporation Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.39 Toshiba medical system corporation Total Operating Income 2015-2019 (US$m)
Table 18.40 Toshiba medical system corporation Total Net Income 2015-2019 (US$m, AGR%)
Table 18.41 Toshiba medical system corporation Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.42 Toshiba medical system corporation Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.43 Samsung medison Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.44 Samsung medison Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.45 Samsung medison Total Operating Income 2015-2019 (US$m)
Table 18.46 Samsung medison Total Net Income 2015-2019 (US$m, AGR%)
Table 18.47 Samsung medison Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.48 Samsung medison Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.49 Mindray Medical International Limited Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.50 Mindray Medical International Limited Company Sales 2015-2019 (US$m, AGR%)
Table 18.51 Mindray Medical International Limited Operating Income 2015-2019 (US$m)
Table 18.52 Mindray Medical International Limited Total Net Income 2015-2019 (US$m, AGR%)
Table 18.53 Mindray Medical International Limited Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.54 Mindray Medical International Limited Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.55 HutChison china Meditech Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.56 HutChison china Meditech Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.57 HutChison china Meditech Total Operating Income 2015-2019 (US$m)
Table 18.58 HutChison china Meditech Total Net Income 2015-2019 (US$m, AGR%)
Table 18.59 HutChison china Meditech Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.60 HutChison china Meditech Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.61 Cardinal health Inc Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.62 Cardinal health Inc Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.63 Cardinal health Inc Total Operating Income 2015-2019 (US$m)
Table 18.64 Cardinal health Inc Total Net Income 2015-2019 (US$m, AGR%)
Table 18.65 Cardinal health Inc Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.66 Cardinal health Inc Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.67 Intelligent Ultrasound Group Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.68 Intelligent Ultrasound Group Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.69 Intelligent Ultrasound Group Total Operating Income 2015-2019 (US$m)
Table 18.70 Intelligent Ultrasound Group Total Net Income 2015-2019 (US$m, AGR%)
Table 18.71 Intelligent Ultrasound Group Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.72 Intelligent Ultrasound Group Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.73 Elbit Medical Technologies Ltd Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.74 Elbit Medical Technologies Ltd Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.75 Elbit Medical Technologies Ltd Total Operating Income 2015-2019 (US$m)
Table 18.76 Elbit Medical Technologies Ltd Total Net Income 2015-2019 (US$m, AGR%)
Table 18.77 Elbit Medical Technologies Ltd Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.78 Elbit Medical Technologies Ltd Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.79 SuperSonic Imagine SA Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.80 SuperSonic Imagine SA Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.81 SuperSonic Imagine SA Total Operating Income 2015-2019 (US$m)
Table 18.82 SuperSonic Imagine SA Total Net Income 2015-2019 (US$m, AGR%)
Table 18.83 SuperSonic Imagine SA Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.84 SuperSonic Imagine SA Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.85 Abbott Laboratories Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.86 Abbott Laboratories Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.87 Abbott Laboratories Total Operating Income 2015-2019 (US$m)
Table 18.88 Abbott Laboratories Total Net Income 2015-2019 (US$m, AGR%)
Table 18.89 Abbott Laboratories Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.90 Abbott Laboratories Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.91 Boston Scientific Corporation Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.92 Boston Scientific Corporation Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.93 Boston Scientific Corporation Total Operating Income 2015-2019 (US$m)
Table 18.94 Boston Scientific Corporation Total Net Income 2015-2019 (US$m, AGR%)
Table 18.95 Boston Scientific Corporation Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.96 Boston Scientific Corporation Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.97 Stryker Corporation Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.98 Stryker Corporation Total Company Sales 2015-2019 (US$m, AGR%)
Table 18.99 Stryker Corporation Total Operating Income 2015-2019 (US$m)
Table 18.100 Stryker Corporation Total Net Income 2015-2019 (US$m, AGR%)
Table 18.101 Stryker Corporation Total EBITDA 2015-2019 (US$m, AGR%)
Table 18.102 Stryker Corporation Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.103 Esaote SpA Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.104 Esaote SpA Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
Table 18.105 KPI Healthcare Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.106 BK Ultrasound Profile 2020 (CEO, Total Company Sales US$bn, Net Income US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 18.107 BK Ultrasound Selected Recent Acquisitions, Contracts, New Product Launches, Others (Date, Development Type, Details)
LIST OF FIGURES
Figure 1.1 Global Cardiovascular Ultrasound Market Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 1.2 Non communicable Diseases Mortality Share, by Cause of Death, 2016(%)
Figure 1.3 Global Cardiovascular Ultrasound Market Segmentation 2020
Figure 4.1 Global Cardiovascular Ultrasound Market Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 4.2 Global Cardiovascular Ultrasound Market Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 4.3 Global Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 4.4 Global Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 4.5 Global Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 4.6 Global Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 4.7 Global Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 4.8 Global Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 5.1 Global Adult Population with Cardiovascular Conditions, by Region, 2019 (%)
Figure 5.2 Population aged 65 and above in G7 countries, 2019 (%)
Figure 6.1 Global Cardiovascular Ultrasound Market Share by Test Type Forecast 2020, 2025, 2030 (%)
Figure 6.2 Global Transthoracic Echocardiography Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 6.3 Global Transoesophageal Echocardiography Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 6.4 Global Stress Echocardiography Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 6.5 Global Other Test Type Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 7.1 Global Cardiovascular Ultrasound Market Share by Technology Forecast 2020, 2025, 2030 (%)
Figure 7.2 Global 2D Technology Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 7.3 Global 3D & 4D Technology Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 7.4 Global Doppler Imaging Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 7.5 Global Other Technology Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 8.1 Global Cardiovascular Ultrasound Market Share by Display Type Forecast 2020, 2025, 2030 (%)
Figure 8.2 Global Colour Display Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 8.3 Global Black&White Display Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 8.4 Global Other Display Type Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 9.1 Global Cardiovascular Ultrasound Market Share by Portability Forecast 2020, 2025, 2030 (%)
Figure 9.2 Global Fixed Devices Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 9.3 Global Portable Devices Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 9.4 Global Hand-Held Devices Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 9.5 Global Other Portability Cardiovascular Ultrasound Market by Region Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 10.1 Global Cardiovascular Ultrasound Market Share by End-User Forecast 2020, 2025, 2030 (%)
Figure 10.2 Global Hospital Cardiovascular Ultrasound Market by Region, Forecast 2020-2030 (US$Million, AGR %)
Figure 10.3 Global Ambulatory Centers Cardiovascular Ultrasound Market by Region, Forecast 2020-2030 (US$Million, AGR %)
Figure 10.4 Global Diagnostic Centers Cardiovascular Ultrasound Market by Region, Forecast 2020-2030 (US$Million, AGR %)
Figure 11.1 North America Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 11.2 North America Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 11.3 North America Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 11.4 North America C
ardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 11.5 North America Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 11.6 North America Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 11.7 North America Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 11.8 North America Cardiovascular Ultrasound Market Share by Country Forecast 2020, 2025, 2030 (%)
Figure 11.9 North America Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.1 Europe Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.2 Europe Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 12.3 Europe Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.4 Europe Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.5 Europe Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.6 Europe Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.7 Europe Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 12.8 Europe Cardiovascular Ultrasound Market Share by Country Forecast 2020, 2025, 2030 (%)
Figure 12.9 Europe Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.1 Asia-Pacific Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.2 Asia-Pacific Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 13.3 Asia-Pacific Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.4 Asia-Pacific Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.5 Asia-Pacific Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.6 Asia-Pacific Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.7 Asia-Pacific Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 13.8 Asia-Pacific Cardiovascular Ultrasound Market Share by Country Forecast 2020, 2025, 2030 (%)
Figure 13.9 Asia-Pacific Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.1 Middle East & Africa Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.2 Middle East & Africa Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 14.3 Middle East & Africa Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.4 Middle East & Africa Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.5 Middle East & Africa Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.6 Middle East & Africa Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.7 Middle East & Africa Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 14.8 Middle East & Africa Cardiovascular Ultrasound Market Share by Country Forecast 2020, 2025, 2030 (%)
Figure 14.9 Middle East & Africa Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.1 Latin America Cardiovascular Ultrasound Market by Value Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.2 Latin America Cardiovascular Ultrasound Market by Volume Forecast 2020-2030 (Thousand Units, AGR %, CAGR %)
Figure 15.3 Latin America Cardiovascular Ultrasound Market by Test Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.4 Latin America Cardiovascular Ultrasound Market by Technology Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.5 Latin America Cardiovascular Ultrasound Market by Display Type Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.6 Latin America Cardiovascular Ultrasound Market by Portability Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.7 Latin America Cardiovascular Ultrasound Market by End-User Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 15.8 Latin America Cardiovascular Ultrasound Market Share by Country Forecast 2020, 2025, 2030 (%)
Figure 15.9 Latin America Cardiovascular Ultrasound Market by Country Forecast 2020-2030 (US$Million, AGR %, CAGR %)
Figure 17.1 COVID-19 Scenarios for the Global Ultrasound Market
Figure 18.1 Canon Medical Systems Corporation Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.2 Canon Medical Systems Corporation Total Operating Income 2015-2019 (US$m)
Figure 18.3 Canon Medical Systems Corporation Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.4 Canon Medical Systems Corporation Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.5 Canon Medical Systems Corporation Primary Market Competitors 2020
Figure 18.6 Koninklijke Philips N.V. Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.7 Koninklijke Philips N.V. Total Operating Income 2015-2019 (US$m)
Figure 18.8 Koninklijke Philips N.V. Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.9 Koninklijke Philips N.V. Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.10 Koninklijke Philips N.V.Primary Market Competitors 2020
Figure 18.11 Hitachi Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.12 Hitachi Total Operating Income 2015-2019 (US$m)
Figure 18.13 Hitachi Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.14 Hitachi Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.15 Hitachi Primary Market Competitors 2020
Figure 18.16 Fujifilm Medical Systems Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.17 Fujifilm Medical Systems Total Operating Income 2015-2019 (US$m)
Figure 18.18 Fujifilm Medical Systems Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.19 Fujifilm Medical Systems Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.20 Fujifilm Medical Systems Primary Market Competitors 2020
Figure 18.21 GE Healthcare Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.22 GE Healthcare Total Operating Income 2015-2019 (US$m)
Figure 18.23 GE Healthcare Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.24 GE HealthcareTotal EBITDA 2015-2019 (US$m, AGR%)
Figure 18.25 GE Healthcare Primary Market Competitors 2020
Figure 18.26 Siemens Healthcare Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.27 Siemens Healthcare Total Operating Income 2015-2019 (US$m)
Figure 18.28 Siemens Healthcare Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.29 Siemens Healthcare Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.30 Siemens Healthcare Primary Market Competitors 2020
Figure 18.31 Toshiba medical system corporation Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.32 Toshiba medical system corporation Total Operating Income 2015-2019 (US$m)
Figure 18.33 Toshiba medical system corporation Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.34 Toshiba medical system corporation Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.35 Toshiba medical system corporation Primary Market Competitors 2020
Figure 18.36 Samsung Medison Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.37 Samsung medison Total Operating Income 2015-2019 (US$m)
Figure 18.38 Samsung medison Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.39 Samsung medison Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.40 Samsung medison Primary Market Competitors 2020
Figure 18.41 Mindray Medical International Limited Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.42 Mindray Medical International Limited Operating Income 2015-2019 (US$m)
Figure 18.43 Mindray Medical International Limited Net Income 2015-2019 (US$m, AGR%)
Figure 18.44 Mindray Medical International Limited Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.45 Mindray Medical International Limited Primary Market Competitors 2020
Figure 18.46 HutChison china Meditech Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.47 HutChison china Meditech Total Operating Income 2015-2019 (US$m)
Figure 18.48 HutChison china Meditech Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.49 HutChison china Meditech Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.50 HutChison china Meditech Primary Market Competitors 2020
Figure 18.51 Cardinal health Inc Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.52 Cardinal health Inc Total Operating Income 2015-2019 (US$m)
Figure 18.53 Cardinal health Inc Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.54 Cardinal health Inc Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.55 Cardinal health Inc Primary Market Competitors 2020
Figure 18.56 Intelligent Ultrasound Group Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.57 Intelligent Ultrasound Group Total Operating Income 2015-2019 (US$m)
Figure 18.58 Intelligent Ultrasound Group Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.59 Intelligent Ultrasound Group Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.60 Intelligent Ultrasound Group Primary Market Competitors 2020
Figure 18.61 Elbit Medical Technologies Ltd Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.62 Elbit Medical Technologies Ltd Total Operating Income 2015-2019 (US$m)
Figure 18.63 Elbit Medical Technologies Ltd Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.64 Elbit Medical Technologies Ltd Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.65 Elbit Medical Technologies Ltd Primary Market Competitors 2020
Figure 18.66 SuperSonic Imagine SA Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.67 SuperSonic Imagine SA Total Operating Income 2015-2019 (US$m)
Figure 18.68 SuperSonic Imagine SA Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.69 SuperSonic Imagine SA Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.70 SuperSonic Imagine SA Primary Market Competitors 2020
Figure 18.71 Abbott Laboratories Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.72 Abbott Laboratories Total Operating Income 2015-2019 (US$m)
Figure 18.73 Abbott Laboratories Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.74 Abbott Laboratories Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.75 Abbott Laboratories Primary Market Competitors 2020
Figure 18.76 Boston Scientific Corporation Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.77 Boston Scientific Corporation Total Operating Income 2015-2019 (US$m)
Figure 18.78 Boston Scientific Corporation Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.79 Boston Scientific Corporation Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.80 Boston Scientific Corporation Primary Market Competitors 2020
Figure 18.81 Stryker Corporation Total Company Sales 2015-2019 (US$m, AGR%)
Figure 18.82 Stryker Corporation Total Operating Income 2015-2019 (US$m)
Figure 18.83 Stryker Corporation Total Net Income 2015-2019 (US$m, AGR%)
Figure 18.84 Stryker Corporation Total EBITDA 2015-2019 (US$m, AGR%)
Figure 18.85 Stryker Corporation Primary Market Competitors 2020
Figure 18.86 Esaote S.p.A.,Primary Market Competitors 2020
Figure 18.87 KPI Healthcare,Primary Market Competitors 2020
Figure 18.88 BK Ultrasound Primary Market Competitors 2020
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
